Sreevidya Sivaswamy

Sreevidya Sivaswamy is a seasoned professional in the field of pharmacovigilance and safety evaluation, currently serving as the Director of Safety Evaluation & Risk Management at GSK since February 2022. Prior experience includes roles as a Senior Safety Scientist and PV & Patient Safety Scientist at PRA Health Sciences, as well as a Safety Scientist/Aggregate Safety Reporting Manager within the Strategic Solutions Division of the same organization. Earlier in the career, Sreevidya worked as a Senior Medical Safety Writer and Medical Writer III at Baxter Healthcare Corporation, and began in research at the Department of Molecular Pharmacology and Therapeutics at Loyola University Chicago. Sreevidya holds a Ph.D. in Molecular and Cellular Biochemistry from Loyola University Chicago and a Master's degree in Biochemistry from the University of Madras.